| 000 | 01756 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514035213.0 | ||
| 264 | 0 | _c20020725 | |
| 008 | 200207s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1038/sj.bjc.6600413 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGraziano, F | |
| 245 | 0 | 0 |
_aPotential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cJun 2002 |
||
| 300 |
_a1854-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcarnitine _xtherapeutic use |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCarnitine _xblood |
| 650 | 0 | 4 |
_aCisplatin _xadverse effects |
| 650 | 0 | 4 |
_aFatigue _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIfosfamide _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xcomplications |
| 650 | 0 | 4 |
_aNootropic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBisonni, R | |
| 700 | 1 | _aCatalano, V | |
| 700 | 1 | _aSilva, R | |
| 700 | 1 | _aRovidati, S | |
| 700 | 1 | _aMencarini, E | |
| 700 | 1 | _aFerraro, B | |
| 700 | 1 | _aCanestrari, F | |
| 700 | 1 | _aBaldelli, A M | |
| 700 | 1 | _aDe Gaetano, A | |
| 700 | 1 | _aGiordani, P | |
| 700 | 1 | _aTesta, E | |
| 700 | 1 | _aLai, V | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 86 _gno. 12 _gp. 1854-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6600413 _zAvailable from publisher's website |
| 999 |
_c11979660 _d11979660 |
||